Crescent Biopharma

Advancing innovative therapies for patients with cancer, guided by science and purpose. Hear from our team on what we’re building, and what drives us forward: bit.ly/4u7I9Z0

Last week, #TeamCrescent celebrated Core Values Day, bringing employees & families together to reflect on the values that shape how we work, collaborate & deliver for patients. It was a meaningful opportunity to celebrate the culture that brings us together in a shared mission.

June is #CancerImmunotherapy Month. At Crescent, we’re developing potential next-gen therapies, with the goal of improving outcomes for people living with cancer. We join the @CancerResearch Institute in recognizing the progress of immunotherapy and its impact on patients.

On Monday, Crescent is participating in the Goldman Sachs Annual Global Healthcare Conference in Miami at 8:40 a.m. ET. Tune in to the webcast: bit.ly/4vzc39P #GoldmanSachsHealthcare

We rang the @NasdaqExchange closing bell this week! An exciting moment for our team & motivation to continue advancing new therapies with the goal of improving outcomes for people living with cancer. Thank you to our team, partners & the patients who inspire our mission. $CBIO

Today, Crescent is participating in the Jefferies Global Healthcare Conference in New York at 4:20pm ET. Tune in to the webcast: bit.ly/4fWNiQ3 #JefferiesHealthcare

Thank you to @NasdaqExchange for hosting #TeamCrescent!

We’re on the ground at #ASCO26 in Chicago! Stop by our Trial-in-Progress poster (TPS2693) about the ASCEND study design evaluating CR-001, our PD-1 x VEGF bispecific investigational therapy for advanced solid tumors. View our poster: bit.ly/4u01Q5O

Heading to #ASCO26? We’re looking forward to connecting with colleagues across the oncology community, exchanging ideas, and highlighting our efforts to develop innovative therapies for people living with cancer. See you in Chicago!

Today, Crescent is participating in a fireside chat at the TD Cowen Annual Oncology Innovation Summit: Insights for ASCO & EHA at 11:30 a.m. ET. Register to tune in to the webcast: bit.ly/42Q9Ie3

Crescent will present a Trial-in-Progress poster at #ASCO26 highlighting ASCEND, our ongoing global Phase 1/2 clinical trial of CR-001, an investigational PD-1 x VEGF bispecific antibody, for the treatment of advanced solid tumors. Learn more: bit.ly/4nNSeJg

Tune in today at 2:30 p.m. ET to listen to Crescent participate in a virtual fireside chat at the Stifel Virtual Targeted Oncology Forum. Register to join the webcast: bit.ly/48WCTji

We’re proud to support #NationalCancerResearchMonth with @AACR and this year’s theme: #UnitedByCancerResearch. At Crescent, we’re contributing to that effort by advancing a robust oncology pipeline with the goal of delivering the next standard of care.

Today, Crescent is participating in a fireside chat at the @BankofAmerica 2026 Healthcare Conference in Las Vegas at 4:20 p.m. PT/7:20 p.m. ET. Register to tune in to the webcast: bit.ly/3OZzp8X

Meet Wenjie Cheng, Ph.D., SVP of Technical Operations at Crescent who leads our CMC strategy and manufacturing. With 20+ years of industry experience, she brings deep expertise in antibody and ADC development and production. We’re grateful for her operational leadership!

Today Crescent reported first quarter 2026 financial results and recent business highlights. For details, read our press release: bit.ly/3OCgm4q

#TeamCrescent is growing – and we’re looking for people who want to help build what’s next in oncology. Join us to help deliver the next wave of transformative therapies and make a meaningful impact for patients. Explore roles: crescentbiopharma.com/careers/

Today, on #AdministrativeProfessionalsDay, we’re celebrating the incredible individuals behind the scenes who keep #TeamCrescent running. Their coordination and dedication to our team helps power the progress behind everything we do for patients.

Earlier this month, #TeamCrescent volunteered at @AmericanCancer Society’s Boston Hope Lodge – cooking & sharing a meal with patients & families undergoing cancer treatment. Experiences like this bring our mission to life & reinforce a culture centered on patients & community.

April is #CancerControlMonth, established in 1938 to promote prevention and early detection – an effort that remains just as important today. At Crescent, we’re focused on advancing the next wave of therapies to drive continued progress in cancer care.